15
Participants
Start Date
July 31, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
NY-ESO-1 combined with MPLA
Each patient will receive six doses of the formulation, administered intra-muscular, with an interval of 4 weeks between doses, and the first immunization performed 6 weeks after the completion of standard treatment. NY-ESO-1 (250 mcg) amd MPLA (100 mcg).
NY-ESO-1 combined with MPLA vaccine
Immunization os cancer patients with NY-ESO-1 combined with MPLA vaccine
Hospital das Clinicas da FMUSP, São Paulo
Collaborators (1)
Butantan Institute
OTHER_GOV
Instituto de Investigação em Imunologia
OTHER